Genetic variations in SLC3A2/CD98 gene as prognosis predictors in non‐small cell lung cancer

E-ISSN： 1098-2744|54|S1|E52-E60

ISSN： 0899-1987

Source： Molecular Carcinogenesis, Vol.54, Iss.S1, 2015-06, pp. : E52-E60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non‐small cell lung cancer patients

Thoracic Cancer, Vol. 6, Iss. 5, 2015-09 ,pp. : 620-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Platelet‐to‐lymphocyte ratio predicts the prognosis of patients with non‐small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 112-119

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human leukocyte antigen (HLA)‐G gene polymorphism in patients with non‐small cell lung cancer

Thoracic Cancer, Vol. 6, Iss. 5, 2015-09 ,pp. : 613-619

John Wiley & Sons Inc

Access to resources Recommend Favorite

CRTC2 promotes non‐small cell lung cancer A549 migration and invasion in vitro

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 136-141

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selection of proper candidates with resected pathological stage IIIA‐N2 non‐small cell lung cancer for postoperative radiotherapy

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 346-353

John Wiley & Sons Inc

Access to resources Recommend Favorite